Erin F Cobain

7PUBLICATIONS
61CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 30, 2026
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With High Tumor Mutation Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.

|Mar 10, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

Natasha B Hunter, Heather A Parsons, Leslie Cope

|Nov 19, 2024
Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast Cancers.

Alejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai

|Sep 19, 2022
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update Q and A.

Amy S Clark, Erin F Cobain, Zoneddy Dayao

|Jun 29, 2022
Recent Advances in Adjuvant Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.

Erin F Cobain, Daniel F Hayes

|Sep 15, 2021
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial.

Costanza Paoletti, William E Barlow, Erin F Cobain

Pageof 2

Frequent Collaborators

2 joint publications

Julie R Gralow

2 joint publications

Lajos Pusztai

2 joint publications

Daniel F Hayes

2 joint publications

Rita Nanda